FDA strengthens device monitoring

Following a 12-month examination of the way medical devices are monitored for safety after approval, the USA's Food and Drug Administration (FDA) has launched a new programme to `transform and strengthen´ current monitoring of new technology as well as existing products.

The FDA Center for Devices and Radiological Health’s (CDRH) Postmarket Transformation Initiative aims to identify, analyse and act on problems more quickly, and alert the public sooner about potential medical device issues.

The Initiative will focus on: Developing an electronic reporting system for adverse medical device events; ways to identify medical devices including standardized and globally accepted names; ways to improve device information in patient records; improved internal collaboration on post market safety issues; and identifying opportunities to improve medical device safety via collaborative efforts with professional organizations and the medical device industry.

Initially, the CDRH’s Medical Device Postmarket Safety Program report, and accompanying recommendations for possible ways to address areas that need improvement, will be reviewed.

01.03.2006

Related articles

Photo

News • Self-sustaining thermoelectric system

e-Tattoo detects infections from skin temperature

An international research team has developed an intelligent device capable of monitoring the skin continuously and accurately detect temperature variations associated with inflammation and infection.

Photo

News • Using pulsatile cranial expansion waveforms

New sensor registers intracranial pressure non-invasively

A novel sensor placed on a patient’s head registers nanometric expansions of the skull in each cardiac cycle in real time to measure intracranial pressure more accurately and non-invasively.

Photo

News • Multifunctional wearable

Smart patch combines health monitoring and drug delivery

Researchers developed a smart patch capable of real-time biometric signal monitoring and drug delivery. Potential applications include glucose management, pain relief, and chronic disease treatment.

Related products

Subscribe to Newsletter